Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
07/09/2026 24:04
BRIEF-Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer Sept 7 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX:
NEURIZON APPOINTS CHIEF EXECUTIVE OFFICER
APPOINTS CHRIS BREMER AS CEO EFFECTIVE 1 OCTOBER 2026
Further company coverage: NUZ.AX
((reuters.briefs@thomsonreuters.com))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility